In this episode of Anesthesia Alchemy, Garry and Terry briefly discuss the history, physiology, and pharmacology of using non-depolarizing neuromuscular blocking drugs as anesthesia adjuncts. They focus on the pitfalls of administrating these agents to surgical patients and the problems associated with residual neuromuscular blockade in the post-anesthesia care unit. Here’s some of what we discuss in this episode: What are cyclodextrins and why are they useful? Understanding the essentials of neuromuscular transmission. What some of the newer intermediate-acting neuromuscular drugs do and how they work. How the treatment has changed through the years. Monitoring recovery from neuromuscular blockade. Running through the eight recommendations that were published. Visit us online and get show references here: https://beyondthemaskpodcast.com/ Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related